Abstract
The effect of a prickly pear peel extract on cholesterol excretion and plasma and hepatic cholesterol levels in hamsters with induced hypercholesterolemia was investigated. Female and male hamsters were fed for 5 weeks with experimental diets: NC, normal cholesterol diet; HC, hypocholesterolemic diet; HCOp, HC with prickly pear peel extract and HCPh, HC with phytosterols. Male and females hamsters fed HCOp diet increased their neutral fecal sterols (cholesterol + coprastanol) excretion by 77% (p<0.042) and 120% (p<0.003), respectively, compared to counterparts fed HC diet. Plasma total cholesterol was significantly reduced only in male hamsters fed HCPh. The phytosterols content in HCOp diet was almost 5 fold less compared to HCPh, and both treatments have reduced 35% (p<0.0001) hepatic cholesterol compared to hamsters fed the HC diet. Thus, the prickly pear peel extract rich in phytosterols showed a hypocholesterolemic effect. This evidence suggests that the prickly pear byproduct tested herein has potential to be employed as ingredient or supplement to lower cholesterol and prevent cardiovascular diseases.
Keywords: Byproduct, hamster, hypocholesterolemic effect, phytosterol, prickly pear peel.
Graphical Abstract
Current Bioactive Compounds
Title:An Extract from Prickly Pear Peel (Opuntia ficus-indica) Affects Cholesterol Excretion and Hepatic Cholesterol Levels in Hamsters Fed Hyperlipidemic Diets
Volume: 12 Issue: 1
Author(s): Ada K. Milán-Noris, Rocio A. Chavez-Santoscoy, Andrea Olmos-Nakamura, Janet A. Gutiérrez-Uribe and Sergio O. Serna-Saldívar
Affiliation:
Keywords: Byproduct, hamster, hypocholesterolemic effect, phytosterol, prickly pear peel.
Abstract: The effect of a prickly pear peel extract on cholesterol excretion and plasma and hepatic cholesterol levels in hamsters with induced hypercholesterolemia was investigated. Female and male hamsters were fed for 5 weeks with experimental diets: NC, normal cholesterol diet; HC, hypocholesterolemic diet; HCOp, HC with prickly pear peel extract and HCPh, HC with phytosterols. Male and females hamsters fed HCOp diet increased their neutral fecal sterols (cholesterol + coprastanol) excretion by 77% (p<0.042) and 120% (p<0.003), respectively, compared to counterparts fed HC diet. Plasma total cholesterol was significantly reduced only in male hamsters fed HCPh. The phytosterols content in HCOp diet was almost 5 fold less compared to HCPh, and both treatments have reduced 35% (p<0.0001) hepatic cholesterol compared to hamsters fed the HC diet. Thus, the prickly pear peel extract rich in phytosterols showed a hypocholesterolemic effect. This evidence suggests that the prickly pear byproduct tested herein has potential to be employed as ingredient or supplement to lower cholesterol and prevent cardiovascular diseases.
Export Options
About this article
Cite this article as:
K. Milán-Noris Ada, A. Chavez-Santoscoy Rocio, Olmos-Nakamura Andrea, A. Gutiérrez-Uribe Janet and O. Serna-Saldívar Sergio, An Extract from Prickly Pear Peel (Opuntia ficus-indica) Affects Cholesterol Excretion and Hepatic Cholesterol Levels in Hamsters Fed Hyperlipidemic Diets, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666151231183553
DOI https://dx.doi.org/10.2174/1573407212666151231183553 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Current Gene Therapy Flavonoids Isolated from Rumex aquaticus Exhibit Neuroprotective and Neurorestorative Properties by Enhancing Neurite Outgrowth and Synaptophysin
CNS & Neurological Disorders - Drug Targets Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design Bioactive Fish Fatty Acids: Health Effects and Their Use as Functional Food Ingredients
Current Nutrition & Food Science The Update of NGAL in Acute Kidney Injury
Current Protein & Peptide Science Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry A Review of Hypertension Management in Atrial Fibrillation
Current Hypertension Reviews Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential Antibacterial Activity of Yemeni Sidr Honey Against <i>Pseudomonas aeruginosa</i> and <i>Streptococcus pyogenes</i>
Anti-Infective Agents Prolonged Perfusion Predicts Recurrent Ischemic Stroke but not Transient Ischemic Attack in Patients with Symptomatic Intracranial Stenosis
Current Neurovascular Research Redox Homeostasis, Bioactive Agents and Transduction Therapy
Current Signal Transduction Therapy Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification
Current Drug Targets The Coronary Circulation in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiovascular Remodeling Induced by Passive Smoking
Inflammation & Allergy - Drug Targets (Discontinued) Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways
Current Molecular Medicine Large Unrepaired Aortopulmonary Window Presenting in Adulthood
Current Cardiology Reviews Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
Current Vascular Pharmacology Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries
Current Pharmacogenomics and Personalized Medicine MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Current Alzheimer Research